Literature DB >> 16102448

It is time to stop ignoring malignancy in heart transplantation: a call to arms.

Paul J Hauptman1, Mandeep R Mehra.   

Abstract

Increasing numbers of patients are surviving more than 5 years after heart transplantation. Despite the dramatic nature of coronary allograft vasculopathy, Cardiac Transplant Research Database data have shown, and International Society for Heart and Lung Transplantation Registry data suggest, that malignancy is the leading cause of death among long-term survivors of heart transplantation. Recommendations on malignancy screening are provided as well as an outline of areas of ongoing uncertainty.

Entities:  

Mesh:

Year:  2005        PMID: 16102448     DOI: 10.1016/j.healun.2004.06.009

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  3 in total

1.  Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Bastian Schmack; Berthold Klein; Christian Erbel; Christian A Gleissner; Mohammadreza Akhavanpoor; Lutz Frankenstein; Fabrice F Darche; Dierk Thomas; Philipp Ehlermann; Tom Bruckner; Hugo A Katus; Andreas O Doesch
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

2.  COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Bastian Schmack; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Hugo A Katus; Philipp Ehlermann; Andreas O Doesch
Journal:  Clin Epidemiol       Date:  2018-09-27       Impact factor: 4.790

3.  Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation.

Authors:  Karsten M Heil; Matthias Helmschrott; Fabrice F Darche; Tom Bruckner; Philipp Ehlermann; Michael M Kreusser; Andreas O Doesch; Wiebke Sommer; Gregor Warnecke; Norbert Frey; Rasmus Rivinius
Journal:  Life (Basel)       Date:  2021-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.